GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » Total Assets

Brawn Biotech (BOM:530207) Total Assets : ₹145.9 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech Total Assets?

Brawn Biotech's Total Assets for the quarter that ended in Mar. 2024 was ₹145.9 Mil.

During the past 12 months, Brawn Biotech's average Total Assets Growth Rate was -7.30% per year. During the past 3 years, the average Total Assets Growth Rate was -1.00% per year. During the past 5 years, the average Total Assets Growth Rate was -9.80% per year. During the past 10 years, the average Total Assets Growth Rate was -0.30% per year.

During the past 13 years, Brawn Biotech's highest 3-Year average Total Assets Growth Rate was 48.60%. The lowest was -15.30%. And the median was 9.80%.

Total Assets is connected with ROA %. Brawn Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was -9.37%. Total Assets is also linked to Revenue through Asset Turnover. Brawn Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.24.


Brawn Biotech Total Assets Historical Data

The historical data trend for Brawn Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech Total Assets Chart

Brawn Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.87 138.74 137.85 145.31 145.89

Brawn Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.31 - 117.25 - 145.89

Brawn Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Brawn Biotech's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=50.65+95.238
=145.9

Brawn Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=50.65+95.238
=145.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech  (BOM:530207) Total Assets Explanation

Total Assets is connected with ROA %.

Brawn Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-13.672/( (0+145.888)/ 1 )
=-13.672/145.888
=-9.37 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Brawn Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=34.465/( (0+145.888)/ 1 )
=34.465/145.888
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Brawn Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Brawn Biotech (BOM:530207) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines